Fmoc-(S)-3-amino-4-(3-(trifluoromethyl)phenyl)butanoic acid is a non-natural, fluorinated amino acid derivative. It features an Fmoc (9-fluorenylmethoxycarbonyl) protecting group on the amine functionality and a carboxylic acid group, making it a ready-to-use building block for solid-phase peptide synthesis (SPPS). The side chain contains a 3-(trifluoromethyl)phenyl group, which introduces hydrophobicity and potential metabolic stability due to the presence of fluorine atoms. This compound is primarily employed in medicinal chemistry and peptide research as a specialized amino acid residue. Its incorporation into peptide sequences is aimed at modulating the physicochemical properties, bioavailability, and biological activity of the resulting peptides or peptidomimetics. The trifluoromethyl group is a common pharmacophore used to enhance binding affinity and improve the pharmacokinetic profile of drug candidates. As a protected amino acid, it is a key intermediate for constructing peptide-based probes, therapeutics, and diagnostic agents. It is commercially available from suppliers specializing in peptide synthesis reagents and advanced pharmaceutical intermediates.